Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronate for Local Recurrence in Giant Cell Tumor of Bone
NCT01564121Phase 2Terminated
- Sponsor
- CHU de Nantes
- Start
- Jan 2006
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in Giant Cell Tumor of Bone (GCTB), sponsored by CHU de Nantes. Started Jan 2006; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
Giant Cell Tumor of Bone (GCTB)
Beyond the preview
Go deeper on NCT01564121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01564121.